Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP742568.RA0GDe2Ly-dZ7dQdUD6Ieq0FDCUP4PflX2pLd0AVpG-zg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP742568.RA0GDe2Ly-dZ7dQdUD6Ieq0FDCUP4PflX2pLd0AVpG-zg130_assertion type Assertion NP742568.RA0GDe2Ly-dZ7dQdUD6Ieq0FDCUP4PflX2pLd0AVpG-zg130_head.
- NP742568.RA0GDe2Ly-dZ7dQdUD6Ieq0FDCUP4PflX2pLd0AVpG-zg130_assertion description "[Therefore, orexin receptor controlling hypothalamic insulin/leptin actions may be a new target for possible future treatment of hyperglycaemia in patients with type 2 diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP742568.RA0GDe2Ly-dZ7dQdUD6Ieq0FDCUP4PflX2pLd0AVpG-zg130_provenance.
- NP742568.RA0GDe2Ly-dZ7dQdUD6Ieq0FDCUP4PflX2pLd0AVpG-zg130_assertion evidence source_evidence_literature NP742568.RA0GDe2Ly-dZ7dQdUD6Ieq0FDCUP4PflX2pLd0AVpG-zg130_provenance.
- NP742568.RA0GDe2Ly-dZ7dQdUD6Ieq0FDCUP4PflX2pLd0AVpG-zg130_assertion SIO_000772 19489767 NP742568.RA0GDe2Ly-dZ7dQdUD6Ieq0FDCUP4PflX2pLd0AVpG-zg130_provenance.
- NP742568.RA0GDe2Ly-dZ7dQdUD6Ieq0FDCUP4PflX2pLd0AVpG-zg130_assertion wasDerivedFrom befree-2016 NP742568.RA0GDe2Ly-dZ7dQdUD6Ieq0FDCUP4PflX2pLd0AVpG-zg130_provenance.
- NP742568.RA0GDe2Ly-dZ7dQdUD6Ieq0FDCUP4PflX2pLd0AVpG-zg130_assertion wasGeneratedBy ECO_0000203 NP742568.RA0GDe2Ly-dZ7dQdUD6Ieq0FDCUP4PflX2pLd0AVpG-zg130_provenance.